Charu Aggarwal, MD, MPH

Aggarwal C, Sterman D, Dwyer J, Alesi ER, Maldonado F, Mehra R, Bestvina C, Reisenauer J, Patel S, Ibrahim O, Eapen G, Guesdon W, Chung MWH, Duault C, Pichavant MR, Gnjatic S, Kim-Schulze S, Maecker HT, Diers AR, Guo Q, Nichols G, Manzanera A, Barone F, Tak PP. Prolonged survival after systemic immune reactivation by aglatimagene besadenovec plus valacyclovir in immune checkpoint inhibitor-refractory non-small cell lung cancer , J Immunother Cancer, 14: 2026,e015821

Bleiberg BA, Ito M, Marmarelis M, Krishna V, Nimgaonkar V, Zhang H, Royce TJ, Tsutani Y, Kozono D, Aggarwal C. A Computational Histology Artificial Intelligence Prognostic Biomarker in Non-Small Cell Lung Cancer Using the Cancer Genome Atlas , Cancers (Basel), 18: 2026,2916

Lova Sun, Willdragon Wang, Keelia Clemens, Kyle Chang, Leslie Bucheit, Melina E. Marmarelis, Aditi Singh, Corey J. Langer, Roger B. Cohen & Charu Aggarwal Long-term ctDNA reassessment in NSCLC immunotherapy responders , Nature: 2026

Meyer ML, Peters S, Borghaei H, Cascone T, Dacic S, Faivre-Finn C, Leighl N, Paz-Ares L, Aerts J, Aggarwal C, Ahn MJ, Arcila ME, Ardizzoni A, Arrieta O, Awad MM, Bar J, Barlesi F, Bazhenova L, Besse B, Chaft J, Cho BC, Curioni Fontecedro A, DE Ruysscher D, Dingemans AM, Dziadziuszko R, Felip E, Forde P, Gandara DR, Garassino MC, Garcia Campelo R, Garrido Lopez P, Gautschi O, Girard N, Goto Y, Gray J, Hendriks L, Hirsch F, Hui R, Janne PA, Kerr K, Khorshid O, Pechoux CLE, Leal T, Lin JJ, Linardou H, Liu S, Mahrous M, Malapelle U, Mercadante E, Mitsudomi T, Mok T, Mountzios G, Naidoo J, Normanno N, Novello S, Oliveira J, Pappagallo G, Perrone G, Pérol M, Raez LE, Ramella S, Rami-Porta R, Reckamp K, Reguart Aransay N, Remon Masip J, Ricardi U, Ricciuti B, Rodriguez-Abreu D, Rotow JK, Santos ES, Schalper K, Senan S, Seto T, Skoulidis F, Smit EF, Soares M, Solli P, Solomon B, Soo RA, Stahel R, Stiles BM, VAN Schil P, Veronesi G, Wistuba II, Wolf J, Wu YL, Zer A, Rolfo C, Landi L, Cappuzzo F. Bridging evidence and practice: international multidisciplinary consensus on non-metastatic NSCLC , J Thorac Oncol: 2026

Barsouk AA, Yaskolko M, Sussman JH, Sun L, Singh AP, Cohen RB, Aggarwal C, Marmarelis ME, Langer CJ. Poor Performance Status Associated With Inferior Tarlatamab Outcomes in a Large, Multi-institution Real-World Database of Patients With 2L + ES-SCLC , Clin Lung Cancer, 27: 2026,50-55

Wang W, Scholes DG, Watts AC, Roy MA, Singhal S, Kucharczuk JC, Jarrar D, Predina J, Pechet TTV, Sun LL, Singh AP, Cohen RB, Langer CJ, Aggarwal C, Marmarelis ME. EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer , JCO Precis Oncol: 2026

Marmarelis ME, Gilligan AM, Sugihara T, Marquart T, Whipple S, Wang Y, Allen-Coyle TJ, Bhandari NR, Aggarwal C. The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC , Cancers (Basel), 18: 2026,2287

Reisenauer JS, DiBardino DM, Criner GJ, Hunt SJ, Panaro J, Friedberg J, Mansfield AS, Aggarwal C, Bodor JN, Callstrom MR. Safety and pathologic response of neoadjuvant pulsed electric field ablation and systemic therapy in early-stage resectable lung cancer: case series , J Thorac Dis, 18: 2026,669

Bleiberg BA, Scholes DG, Reed-Guy L, Dravid D, Sun LL, Singh AP, Cohen RB, Langer CJ, Marmarelis ME, Aggarwal C. Erratum to "The incremental value of liquid biopsy in the initial evaluation of patients with metastatic non-small cell lung cancer undergoing tissue-based molecular testing" [J. Liq. Biopsy 12 (2026) 100461] , J Liq Biopsy, 12: 2026,100472

Klein M, Watson D, Castro M, Kapoor S, Nair PR, Rajagopalan S, Qin H, Glaser M, Westanmo A, Lala DA, Kumar A, Chauhan J, G P, Ullal YS, Kulkarni S, Narvekar Y, Ghosh A, Tyagi A, Patil M, Macpherson MD, Wingrove JA, Patil T, Aggarwal C, Ganti AK. Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors , Clin Lung Cancer: 2026